Literature DB >> 7749883

Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency.

A von Eckardstein1, Y Huang, S Wu, H Funke, G Noseda, G Assmann.   

Abstract

HDLs encompass structurally heterogenous lipoproteins that fulfill specific functions in reverse cholesterol transport. Two-dimensional nondenaturing gradient gel electrophoresis (2D-PAGGE) of normoalphalipoproteinemic plasma and subsequent immunoblotting with anti-apoA-I-antibodies differentiates pre-beta 1-LpA-I, pre-beta 2-LpA-I, pre-beta 3-LpA-I, alpha-LpA-I2, and alpha-LpA-I3. Immunodetection with anti-apoE antibodies differentiates gamma-LpE and alpha-LpE. Pulse-chase incubations of plasma with [3H]unesterified cholesterol ([3H]UC)-labeled fibroblasts and subsequent 2D-PAGGE revealed that cell-derived [3H]UC is taken up by pre-beta 1-LpA-I and gamma-LpE. From these initial acceptors, [3H]UC is transferred to LDL via pre-beta 2-LpA-I-->pre-beta 3-LpA-I-->alpha-LpA-I. Some UC is esterified in pre-beta 3-LpA-I, and some is esterified in alpha-LpA-I after its retransfer from LDL. In this study we investigated the effect of various forms of familial HDL deficiency on reverse cholesterol transport. Plasma samples of patients with various forms of HDL deficiency are characterized by the lack of specific HDL subclasses. ApoE-containing HDLs, including gamma-LpE, are present in all kinds of HDL deficiency. However, all forms of LpA-I are absent in apoA-I-deficient plasma, pre-beta 3-LpA-I and alpha-LpA-I from the plasma of patients with Tangier disease (TD), and pre-beta 3-LpA-I and large alpha-LpA-I from the plasma of patients with lecithin:cholesterol acyltransferase (LCAT) deficiency and fish-eye disease (FED). After a 1-minute pulse with labeled fibroblasts, efflux of [3H]UC into HDL-deficient plasmas decreased, compared with normal plasma, by 49% (apoA-I deficiency), 36% (TD), 21% (LCAT deficiency), and 28% (FED). In apoA-I deficiency, only gamma-LpE takes up cell-derived [3H]UC. In the three other HDL-deficiency states, cell-derived [3H]UC is initially taken up by both pre-beta 1-LpA-I and gamma-LpE. The four HDL deficiencies are also characterized by differences in the esterification of cell-derived [3H]UC. No esterification occurs in LCAT-deficient plasma. In FED plasma, [3H]UC is esterified in LDL. In apoA-I deficiency and TD, however, [3H]UC is esterified in lipoproteins free of apoA-I and apoB. In the two latter cases, the transfer of [3H]cholesteryl ester to LDL is enhanced compared with normal plasma. The lack of specific HDL subclasses and the consequent changes in reverse cholesterol transport pathways differently affect net mass efflux of cholesterol from fibroblasts into HDL-deficient plasma.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7749883     DOI: 10.1161/01.atv.15.5.691

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  8 in total

1.  In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1.

Authors:  Adriaan G Holleboom; Lily Jakulj; Remco Franssen; Julie Decaris; Menno Vergeer; Joris Koetsveld; Jayraz Luchoomun; Alexander Glass; Marc K Hellerstein; John J P Kastelein; G Kees Hovingh; Jan Albert Kuivenhoven; Albert K Groen; Scott M Turner; Erik S G Stroes
Journal:  J Lipid Res       Date:  2013-05-06       Impact factor: 5.922

2.  Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma.

Authors:  Y Huang; A von Eckardstein; S Wu; G Assmann
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

3.  Compound heterozygosity at the sphingomyelin phosphodiesterase-1 (SMPD1) gene is associated with low HDL cholesterol.

Authors:  Ching Yin Lee; Larbi Krimbou; Jérôme Vincent; Chantal Bernard; Pierre Larramée; Jacques Genest; Michel Marcil
Journal:  Hum Genet       Date:  2003-02-27       Impact factor: 4.132

4.  Analysis of lipid transfer activity between model nascent HDL particles and plasma lipoproteins: implications for current concepts of nascent HDL maturation and genesis.

Authors:  Dana Bailey; Isabelle Ruel; Anouar Hafiane; Haley Cochrane; Iulia Iatan; Matti Jauhiainen; Christian Ehnholm; Larbi Krimbou; Jacques Genest
Journal:  J Lipid Res       Date:  2009-09-29       Impact factor: 5.922

5.  Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma.

Authors:  Y Zhu; S Bellosta; C Langer; F Bernini; R E Pitas; R W Mahley; G Assmann; A von Eckardstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

6.  Postprandial hypertriglyceridaemia in patients with Tangier disease.

Authors:  G Kolovou; D Daskalova; K Anagnostopoulou; I Hoursalas; V Voudris; D P Mikhailidis; D V Cokkinos
Journal:  J Clin Pathol       Date:  2003-12       Impact factor: 3.411

7.  Tachometer for reverse cholesterol transport?

Authors:  Arnold Eckardstein
Journal:  J Am Heart Assoc       Date:  2012-08-24       Impact factor: 5.501

8.  Interaction between VLDL and phosphatidylcholine liposomes generates new γ-LpE-like particles.

Authors:  Agnieszka Ćwiklińska; Barbara Kortas-Stempak; Anna Gliwińska; Anastasis Pacanis; Agnieszka Kuchta; Małgorzata Wróblewska
Journal:  Lipids       Date:  2014-02       Impact factor: 1.880

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.